-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BaTqNw/1gSqkfLypZurrjRX9M/PiGiJDEf4fp6JGEAq93Odg0cWueqMhBzw6P71j eoqy8YnldJMSBohKqsmlfg== 0000950135-04-002358.txt : 20040505 0000950135-04-002358.hdr.sgml : 20040505 20040505172433 ACCESSION NUMBER: 0000950135-04-002358 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040505 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-39145 FILM NUMBER: 04782566 BUSINESS ADDRESS: STREET 1: 1280 MASSACHUSETTS AVENUE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6178687455 MAIL ADDRESS: STREET 1: 1280 MASSACHUSETTS AVE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FLYNN DONALD F CENTRAL INDEX KEY: 0001041890 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O FLYNN ENTERPRISES STREET 2: 676 N MICHIGAN AVE STE 4000 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 3122803718 MAIL ADDRESS: STREET 1: 101 NORTH PINE STREET CITY: SPARTANBURG STATE: SC ZIP: 29302 SC 13G 1 b50559dfsc13g.txt DONALD F. FLYNN RE: PSYCHEMEDICS CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 PSYCHEMEDICS CORPORATION (Name of Issuer) Common Stock Title of Class of Securities 744375205 (CUSIP Number) APRIL 22, 2004 Date of Event which requires filing of this statement Check the appropriate box to designate the rule pursuant to which this schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages CUSIP No. 744375205 Page 2 of 5 pages SCHEDULE 13G 1) Names of Reporting Persons; S.S. or I.R.S. Identification Nos. of Above Persons Donald F. Flynn -------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) ----------------------------------------------------------------------- (b) ----------------------------------------------------------------------- 3) SEC Use Only -------------------------------------------------------------- 4) Citizenship or Place of Organization U.S. Citizen -------------------------------------- Number of Shares 5) Sole Voting Power 334,393 Beneficially Owned --------------------------------- By Each Reporting 6) Shared Voting Power 0 Person With ------------------------------- 7) Sole Dispositive Power 334,393 ---------------------------- 8) Shared Dispositive Power 0 -------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 334,393 -------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) -------------------------------------------------------------------------- 11) Percent of Class Represented by Amount in Row (9) 6.4% ------------------------- 12) Type of Reporting Person (See Instructions) IN ------------------------------- CUSIP No. 744375205 Page 3 of 5 pages SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G Item 1 (a) Name of Issuer: Psychemedics Corporation (b) Address of Issuer's Principal Executive Offices: 1280 Massachusetts Ave., Suite 200 Cambridge, MA 02138 Item 2 (a) Name of Person Filing: Donald F. Flynn (b) Address of Principal Business Office or, if none, Residence: 676 North Michigan Avenue, Suite 4000, Chicago, Illinois 60611 (c) Citizenship: U.S. (d) Title of Class of Securities: Common Stock, $.005 par value (e) CUSIP NUMBER: 744375205 Item 3 If this statement is filed pursuant to Sections 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: Not Applicable CUSIP No. 744375205 Page 4 of 5 pages Item 4 (a) Amount Beneficially Owned: 334,393 (b) Percent of Class: 6.4% (c) Number of Shares as to which such person has: (i) sole power to direct the vote 334,393 (ii) shared power to vote or to direct the vote 0 (iii) sole power to dispose or to direct the disposition of 334,393 (iv) shared power to dispose or to direct the disposition of 0 Item 5 Ownership of Five Percent or Less of a Class: Not Applicable Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable Item 8 Identification and Classification of Members of the Group: Not Applicable Item 9 Notice of Dissolution of Group: Not Applicable CUSIP No. 744375205 Page 4 of 5 pages Item 10 Certification (a) Not Applicable (b) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this statement is true, complete and correct. May 5, 2004 ---------------------------------------- Date /s/ Donald F. Flynn ---------------------------------------- Donald F. Flynn -----END PRIVACY-ENHANCED MESSAGE-----